Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
SKAN Group AG is engaged in the design and manufacture of advanced cleanroom equipment and solutions, primarily servicing the pharmaceutical and biotechnology industries. It specializes in the development of isolator technology used for aseptic production processes, providing critical equipment that ensures sterile manufacturing environments. Founded in 1968, SKAN is headquartered in Allschwil, Switzerland, and has established a strong presence across the global market, including locations in North America, Europe, and Asia. The company's strategic focus lies in its expertise in containment solutions and decontamination processes, which positions it as a key player in supporting its clients’ compliance with stringent safety and quality regulations. SKAN's innovative approach and specialized knowledge have made its products integral to various high-tech pharmaceutical production lines.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
SKAN Group AGEli Lilly
Last price
CHF 75.40$1,417.54
Currency
CHF
USD
CHF 1.7B$1.2T
57.2944.58
CHF 1.33$30.81
0.73-
CHF 0.22$6.69
0.14%0.50%
Sector
HealthHealth
Employees
1,69450,000
Ticker
Fr. SKAN$LLY
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.SKAN or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.